Provided by Tiger Trade Technology Pte. Ltd.

Passage Bio, Inc.

4.39
-0.0500-1.13%
Volume:38.46K
Turnover:167.35K
Market Cap:14.08M
PE:-0.39
High:4.66
Open:4.66
Low:4.30
Close:4.44
52wk High:20.00
52wk Low:3.29
Shares:3.21M
Float Shares:3.20M
Volume Ratio:2.23
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.3124
EPS(LYR):-14.3500
ROE:-169.09%
ROA:-45.62%
PB:3.16
PE(LYR):-0.31

Loading ...

Passage Bio - Terminates Research, Collaboration and License Agreement With Gemma Bio Therapeutics - SEC Filing

THOMSON REUTERS
·
May 28

Passage Bio shareholders elect two directors at annual meeting

Reuters
·
May 26

Analysts’ Top Healthcare Picks: Passage Bio (PASG), Esperion (ESPR)

TIPRANKS
·
May 13

Passage Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Passage Bio posts corporate presentation on PBFT02 gene therapy for frontotemporal dementia

Reuters
·
May 12

Passage Bio Q1 FY26 net loss narrows 50.93% to $7.56 million

Reuters
·
May 12

Passage Bio Inc expected to post a loss of $2.79 a share - Earnings Preview

Reuters
·
May 09

Damora Therapeutics names Brian Burkavage principal financial officer, accounting officer

Reuters
·
May 05

Passage Bio Inc - Expects Aggregate Severance and Exit Costs of $3.3 Mln - SEC Filing

THOMSON REUTERS
·
Apr 28

Passage Bio Inc - to Reduce Workforce by About 75% in Restructuring Plan - SEC Filing

THOMSON REUTERS
·
Apr 28

Passage Bio restructures, cuts workforce about 75% to reduce operating expenses

Reuters
·
Apr 28

Wedbush downgrades Passage Bio to Neutral on regulatory uncertainties

TIPRANKS
·
Apr 21

Passage Bio Seen as Undervalued Despite FDA Setback, Oppenheimer Says

MT Newswires Live
·
Apr 21

Passage Bio Cut to Neutral From Outperform by Wedbush

Dow Jones
·
Apr 21

Passage Bio Inc : TD Cowen Cuts to Hold From Buy

THOMSON REUTERS
·
Apr 21

Passage Bio Inc : Oppenheimer Cuts Target Price to $15 From $30

THOMSON REUTERS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Passage Bio (PASG), Climb Bio (CLYM) and Zai Lab (ZLAB)

TIPRANKS
·
Apr 21

Passage Bio Inc : Wedbush Cuts to Neutral From Outperform; Cuts Target Price to $8 From $32

THOMSON REUTERS
·
Apr 21

Chardan Downgrades Passage Bio to Neutral From Buy, Cuts Price Target to $7 From $21

MT Newswires Live
·
Apr 21

Passage Bio downgraded to Neutral from Buy at Chardan

TIPRANKS
·
Apr 21